(Q61918448)

English

Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study (English)

0 references

0 references

0 references

April 2006

0 references

end time

June 2009

0 references

number of participants

103

0 references

research intervention

metformin

0 references

telmisartan

0 references

angiotensin receptor antagonists

0 references

(RS)-rosiglitazone

0 references

minimum age

40 year

0 references

maximum age

80 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00486187

0 references

(Q61918448)

Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)